| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |